细胞疗法在NSCLC:在神话和现实之间
Martina Imbimbo1, Laureline Wetterwald2, Alex Friedlaender3,4
1Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, Lausanne University Hospital, Lausanne, Switzerland. Martina.imbimbo@chuv.ch.
Current oncology reports
|August 30, 2023
概括
采用细胞疗法 (ACT) 在非小细胞肺癌 (NSCLC) 方面表现有前途. 克服毒性和瘤透等挑战对于扩展ACT至关重要.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是瘤学的重大挑战.
- 采用细胞疗法 (ACT) 已经彻底改变了血液恶性瘤治疗.
- 在包括NSCLC在内的固体瘤中应用ACT仍在调查中.
研究的目的:
- 审查目前NSCLC的ACT的现状和模式.
- 讨论在NSCLC中ACT实施的现有障碍.
- 探索克服NSCLC治疗中的这些挑战的策略.
主要方法:
- 在NSCLC中基于T细胞的ACT正在进行的临床试验的审查.
- 对三种主要ACT模式的分析:瘤透性淋巴细胞 (TIL),T细胞受体 (TCR) 和仿真抗原受体 (CAR) T细胞.
- 检查固体瘤中ACT的局限性和潜在解决方案.
主要成果:
- 目前正在进行NSCLC的几项ACT试验,重点是TIL,TCR和CAR T细胞.
- 与血液癌症相比,CAR T细胞在NSCLC等固体瘤中的疗效目前是有限的.
- 关键的限制包括严重的毒性,瘤透不良,抗原逃逸和制造障碍.
结论:
- 在转移性NSCLC中,ACT有望改善结局.
- 需要大量的翻译和临床研究来提高ACT在NSCLC中的有效性和应用.
- 解决目前的局限性对于释放ACT对肺癌患者的全部潜力至关重要.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

